|
Daniel B. Muscle & T [J]. Nerve, 1996.1239.
|
|
邓安梅, 仲人前. SLE病人淋巴细胞亚群及体液免疫功能分析 [J]. 中国实验诊断学, 1997(5):31.
|
|
罗伊特, 等, 周光炎. 免疫学 [M]. 北京:人民卫生出版社, 2002.126.
|
|
陈艳. 自身免疫病和口服耐受 [J]. 自然杂志, 1999(3):135.doi: 10.3969/j.issn.0253-9608.1999.03.003.
|
|
Kaleryis A M, Nathenson S G. Alterd peptide ligand-mediated TCR antagonism can be modulated by a change in a single amino acid residue within the CDR3 beta of an MHC class Ⅰ-restricted TCR [J]. Journal of Immunology, 2000(1):280.
|
|
沈柱. 以T细胞介导为主的自身免疫性疾病的干预策略 [J]. 细胞与分子免疫学杂志, 2005, (zk):71.doi: 10.3321/j.issn:1007-8738.2005.z1.025.
|
|
Young D A, Lowe L D, Booth S S. IL-4, IL-10, IL-13 and TGF-βfrom an altered peptide ligand-specific Th2 cell clone down-regulate adoptive transfer of experimental autoimmune encephalomyelitis [J]. Journal of Immunology, 2000(7):3563.
|
|
Paas-Rozner M, Sela M, Mozes E. A dual altered peptide ligand down-regulates myasthenogenic T cell responses by upregulating CD25 and CTLA-4 expressing CD4+ T cells [J]. Proceedings of the National Academy of Sciences(USA), 2003(1):6676.doi: 10.1073/pnas.1131898100.
|
|
Faber-Elmanm A, Grabovsky V, Dayan M. An altered peptide ligand inhibits the activities of matrix metalloprote inase-9 and phospholipase C, and inhibits T cell interactions with VCAM-1 induced in vivo by a myasthenogenic T cell epitope [J]. Federation of America Societies for Experimental Biology Journal, 2001(1):187.
|
|
Topham D J, Nay B. A synthetic peptide from the third hypervariable of major histocompatibility complex class Ⅱβchain as a vaccine for treatment of experimental autoimmune enceophalomyelitis [J]. Proceedings of the National Academy of Sciences(USA), 1994.8005.
|
|
Aohiron A, Mandel M. T-cell vaccination in multiple sclerosis [J]. Autoimmunity Reviews, 2004(1):25.doi: 10.1016/S1568-9972(03)00060-0.
|
|
Hashim G A, Vandenbark A A, Ganlang A B. Antibodies specific for Vβ receptor peptide suppress experimental allergic encephalomyelitis [J]. Immunology, 1990.4621.
|
|
Linsley P S, Brady W, Grosmaine L. Binding of the B cell activation antigen BT to CD28 co-stimulates T cell proliferation and interleukin-2 mRNA accumulation [J]. T Exp Med, 1991(3):721.
|
|
Balow T E, Boumpas D T, Austin H A. New prospects for treatment of lupus nephritis [J]. Seminars in Nephrology, 2000(1):32.
|
|
Sato T, Asakura K, murakami M. Topical CTLA4-Ig Suppresses ongoing mucosal immune response in pre-sensitized murine model of allergic rhinitis [J]. International Archives of Allergy and Applied Immunology, 1999(3):197.
|
|
Rieckmann P. Soluble forms of intercellular adhesion molecule-1(ICAM-1)block lymphocyte attachment to cerebral endothelial cells [J]. Neuroimmunomodulation, 1995.9.
|
|
Tuohy V K, Yn M, Yin L. Modulation of the IL-10/IL-12 cytokine circuit by interferon-beta inhibits the development of epitope spreading and disease progression in murine autoimmune encephalomyelitis [J]. Journal of Neuroimmunology, 2000, (1, 2):55.doi: 10.1016/S0165-5728(00)00384-2.
|
|
Windhagen A, Anderson D E, Carrizosa A. Kytikine secretion of myelin basic protein reactive T cells in patients with multiple sclerosis [J]. Journal of Neuroimmunology, 1998, (1, 2):1.doi: 10.1016/S0165-5728(98)00086-1.
|
下载:
苏公网安备 32100302010246号